Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs GUFIC BIOSCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA GUFIC BIOSCIENCE SANOFI INDIA/
GUFIC BIOSCIENCE
 
P/E (TTM) x 31.0 32.6 95.1% View Chart
P/BV x 15.4 7.9 195.2% View Chart
Dividend Yield % 7.0 0.0 19,880.6%  

Financials

 SANOFI INDIA   GUFIC BIOSCIENCE
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
GUFIC BIOSCIENCE
Mar-23
SANOFI INDIA/
GUFIC BIOSCIENCE
5-Yr Chart
Click to enlarge
High Rs7,939290 2,741.8%   
Low Rs5,454177 3,079.7%   
Sales per share (Unadj.) Rs1,202.871.2 1,688.4%  
Earnings per share (Unadj.) Rs269.58.2 3,277.4%  
Cash flow per share (Unadj.) Rs287.710.5 2,734.4%  
Dividends per share (Unadj.) Rs570.000.10 570,000.0%  
Avg Dividend yield %8.50 19,860.4%  
Book value per share (Unadj.) Rs527.035.9 1,468.7%  
Shares outstanding (eoy) m23.0396.94 23.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.63.3 170.0%   
Avg P/E ratio x24.928.4 87.6%  
P/CF ratio (eoy) x23.322.2 105.0%  
Price / Book Value ratio x12.76.5 195.4%  
Dividend payout %211.51.2 17,391.2%   
Avg Mkt Cap Rs m154,22422,620 681.8%   
No. of employees `000NANA-   
Total wages/salary Rs m4,059867 468.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,7016,906 401.1%  
Other income Rs m73026 2,836.1%   
Total revenues Rs m28,4316,932 410.1%   
Gross profit Rs m8,3491,347 620.0%  
Depreciation Rs m419223 188.1%   
Interest Rs m1782 20.7%   
Profit before tax Rs m8,6431,067 809.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,437270 902.1%   
Profit after tax Rs m6,206797 778.6%  
Gross profit margin %30.119.5 154.6%  
Effective tax rate %28.225.3 111.4%   
Net profit margin %22.411.5 194.1%  
BALANCE SHEET DATA
Current assets Rs m36,1214,641 778.3%   
Current liabilities Rs m27,4252,882 951.6%   
Net working cap to sales %31.425.5 123.3%  
Current ratio x1.31.6 81.8%  
Inventory Days Days11735 329.9%  
Debtors Days Days171,086 1.6%  
Net fixed assets Rs m12,1483,961 306.7%   
Share capital Rs m23097 237.2%   
"Free" reserves Rs m11,9063,381 352.1%   
Net worth Rs m12,1363,478 348.9%   
Long term debt Rs m01,907 0.0%   
Total assets Rs m48,2798,602 561.3%  
Interest coverage x509.414.0 3,644.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.8 71.5%   
Return on assets %12.910.2 126.1%  
Return on equity %51.122.9 223.1%  
Return on capital %71.421.3 334.3%  
Exports to sales %14.112.5 113.1%   
Imports to sales %14.639.3 37.1%   
Exports (fob) Rs m3,904860 453.8%   
Imports (cif) Rs m4,0372,716 148.7%   
Fx inflow Rs m3,904860 453.8%   
Fx outflow Rs m4,0372,716 148.7%   
Net fx Rs m-133-1,855 7.2%   
CASH FLOW
From Operations Rs m3,987-266 -1,499.6%  
From Investments Rs m6,509-1,907 -341.3%  
From Financial Activity Rs m-15,8272,343 -675.5%  
Net Cashflow Rs m-5,331170 -3,137.0%  

Share Holding

Indian Promoters % 0.0 72.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 28.8 2.2 1,310.0%  
FIIs % 6.3 0.5 1,342.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 27.5 144.1%  
Shareholders   62,870 34,424 182.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Sanofi India vs GUFIC BIOSCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs GUFIC BIOSCIENCE Share Price Performance

Period Sanofi India GUFIC BIOSCIENCE S&P BSE HEALTHCARE
1-Day 2.06% -0.93% 1.18%
1-Month -8.09% -8.45% -0.75%
1-Year 44.45% 56.26% 61.82%
3-Year CAGR 0.97% 39.23% 18.16%
5-Year CAGR 7.07% 29.02% 19.79%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the GUFIC BIOSCIENCE share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of GUFIC BIOSCIENCE the stake stands at 72.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of GUFIC BIOSCIENCE.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 570.0 per share. This amounted to a Dividend Payout ratio of 211.5%.

GUFIC BIOSCIENCE paid Rs 0.1, and its dividend payout ratio stood at 1.2%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of GUFIC BIOSCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.